GlassScriptPhysician profile
Larissa Rolim
NPI 1144678517
$11,272.01
in general payments reported to CMS, 2019-2025
19 companies · $438 in 2025
The $438 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,717 · 2020: $766 · 2021: $1,686 · 2022: $2,132 · 2023: $1,982 · 2024: $1,551 · 2025: $438.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,249 · Travel and Lodging: $1,722.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,249.36 |
| Travel and Lodging | $1,721.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $2,611.30 | 2019-2024 | |
| Treace Medical Concepts, INC. | $2,526.56 | 2019-2023 | |
| Musculoskeletal Transplant Foundation INC. | $1,906.93 | 2022-2023 | |
| Smith+Nephew, INC. | $1,089.82 | 2021-2025 | Grafix Pl, Stravix Pl, Stravix |
| Arthrosurface Incorporated | $947.42 | 2019 | |
| Paragon 28, INC. | $926.16 | 2024-2025 | Bun-Yo-Matic, Portfolio |
| Stryker Corporation | $323.88 | 2020-2025 | Augment Injectable, Infinity Adaptis, Ortholoc 2 Lapifuse |
| Medtronic, INC. | $223.04 | 2023-2025 | Hawkone, Venaseal |
| Depuy Synthes Sales INC. | $165.76 | 2024-2025 | Motoband, Na, Tfn-Advance |
| Ethicon US, LLC | $133.07 | 2024 | Vistaseal, Stratafix, Dermabond Prineo |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $131.68 | 2021 | |
| Orthofix Medical, INC. | $83.03 | 2019-2025 | Physio-Stim |
| Abbvie INC. | $44.78 | 2021 | |
| Integra Lifesciences Corporation | $40.22 | 2019-2020 | |
| Nabriva Therapeutics, Plc | $34.05 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $33.78 | 2023 | Puraply |
| Trice Medical, INC. | $24.62 | 2020 | |
| Polynovo North America LLC | $15.06 | 2025 | Novosorb Btm |
| Horizon Therapeutics Plc | $10.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larissa Rolim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.